GC Biopharma USA, Inc. has been awarded a Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products. The contract was awarded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The FSS contract has a ceiling value of $25,000 and a period of performance ending on July 4, 2024. This multiple-award vehicle allows various federal agencies to efficiently procure the company's pharmaceutical and hematology products without the need for additional competition for each order.
In addition, GC Biopharma USA, Inc. holds a Blanket Purchase Agreement (BPA) with a ceiling value of $11,920,000, awarded by the National Acquisition Center for ALYGLO products and related services, valid through August 5, 2025. The company's focus appears to be on supplying medical and pharmaceutical products to government entities, particularly within the healthcare sector. The multiple contract awards demonstrate GC Biopharma USA, Inc.'s ongoing eligibility and capacity to participate in federal contracting opportunities.
Generated 2/11/25, 10:07 AM